$BTAI - is it able to keep on the previous trend line?NASDAQ:BTAI oversold and should return to the range for the further trivial trading in 2 months. I believe, it go back. All pictures show that this drop need to be closed and forgotten as a bad dream.
Good possible profit for the risky investors in a short enough range of time.
Does not constitute a recommendation
#investing #stocks #idea #forecast #furoreggs
BTAI trade ideas
BTAI BioXcel Therapeutics Options Ahead of EarningsAnalyzing the options chain and the chart patterns of BTAI BioXcel Therapeutics prior to the earnings report this week,
I would consider purchasing the 3usd strike price Calls with
an expiration date of 2024-3-15,
for a premium of approximately $0.25.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
BTAI | InformativeNASDAQ:BTAI
Technical Analysis for NASDAQ:BTAI :
If the price of BTAI breaks above the bullish line of $11.61, it may indicate a bullish signal, suggesting potential upward price movement. In this scenario, the target price could be set at $16.80.
Conversely, if the price of BTAI breaks below the bearish line of $8.80, it may suggest a bearish signal, implying potential downward price movement. In this case, the target price could be set at $6.80.
$BTAI (Bioxcel Therapeutics - semi-year race with good tipsNASDAQ:BTAI - is it hoing to grow? My answer - it is almost ready to start.
Shown a high level of correcton after the previous long wave, company would like to show nice profit for the investors to this kind of fields.
NASDAQ:BTAI (Bioxcel Therapeutics) :: 21.46->50::+132%::Aug 2023
Does not constitute a recommendation.
#investing #stocks #idea #forecast #furoreggs
Please, subscribe and challenge my point of view )
BTAi Bullish news caused a beautiful pump on this overnight. Although it was looking bearish the news pushed us back up. I am watching 22.68 as it as held us up in premarket but my key levels are 21.40 and 18.91. These are area in interested in trying. As most of the market is bearish , this may attract buyers an retail to swarm to something green. Be cautious. Use stops but this could setup. I need to wait till open to see more chart info but this is what I mapped out for ketcsupports as of now my first add was 22.15 this am
I have a buy at 21.40. And I will add if we reach low as 18.92. Where I will stop out i we reject at 19 if it does dump on open
Play at your own risk but this may be what I will be tracking all day if it does look bullish or setup through the day. I’ll update later if anyon is interested
Added $BTAI Target 42.51 for 47.09% $BTAI Target 42.51 for 47.09%
Or next add at 23.79
There is a bullish RSI divergence on the daily chart... I'd like to see this hold above that trendline...
Just looking at indicators... if it holds I might even add a little more tomorrow for the ride up...
-----
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
ONLY ADD at support levels & FIB levels… labeled
I start every position with .5 - 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
🟢 NEW POSITION $BTAI Target 37.60 for 30.1%$BTAI Target 37.60 for 30.1%
Or double position at 20.20
I took this one earlier today… @28.90… Let’s see what happens…
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
I finally added my YouTube Training Video to my profile tagline since I’m not allowed to on here. It’s a quick 15 minute training video on how to set up your chart and how to spot opportunities. So check here first but If you have questions just message me.
BTAI Symmetrical Triangle Breakout: Potential for 100%+ returnsBTAI has just broken out of a nice bullish symmetrical triangle formation. As you can see from my chart the breakout was backed by strong volume as it occurred at a significantly higher level of volume than seen during the consolidation phase. Now that the breakout has occurred you can also see my GMMA oscillator is dying to cross over into the green. The last and only 2 times the GMMA oscillator turned green on the 1 week chart it was followed by major price run ups. The first time we saw price rise from $5.60 in late December 2019 to $43.75 by Mid February 2020. The second time this occurred we saw price rise from $22.50 in mid April 2020 to $71 by mid July 2020. If we have another strong crossover into the green I fully expect another major run up in price. In addition to T.A I have also set a price target of $105 based on fundamental analysis. When coming to this number I was pretty conservative in my calculations and feel that the real upside may be even higher than this $105 number. Overall I am feeling very bullish on BTAI.
$BTAI:NASDAQ - BIOXCEL - 450% run over the last 12 monthsBioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
$BTAI by Mid-September $74.50Trend outlook by mid-September will hit $74.50, following my own ideas and not paying attention to outside noise. Trials look promising, earning looking very good, and this stock is staying out of the norm for all that I have been reading. My view is that this investment, an opioid withdrawal treatment, will be beneficial for people and in the process help to fund my kids' college tuition.
BioXcel Therapeutics, Inc trade setup $btai
Possible entry level $42.33
target price $52.88
Stop loss $39.43
Company profile
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.